Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity

Obesity

Volumn 22, Issue 8, 2014, Pages 1821-1829

  Balaz, Miroslav ^a   Vician, Marek ^b   Janakova, Zuzana ^a   Kurdiova, Timea ^a   Surova, Martina ^a   Imrich, Richard ^a   Majercikova, Zuzana ^a   Penesova, Adela ^a   Vlcek, Miroslav ^a   Kiss, Alexander ^a   Belan, Vitazoslav ^c   Klimes, Iwar ^a   Olejnik, Juraj ^b   Gasperikova, Daniela ^a   Wolfrum, Christian ^d   Ukropcova, Barbara ^a   Ukropec, Jozef ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^d ETH ZURICH   (Switzerland)

Author keywords

extreme obesity; insulin sensitivity; mitochondria; subcutaneous and visceral adipose tissue; type 2 diabetes; zinc 2 glycoprotein

Indexed keywords

ADIPONECTIN; ALPHA2 GLYCOPROTEIN; FATTY ACID; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; PPARGC1A PROTEIN, HUMAN; SEMINAL PLASMA PROTEIN; SLC2A4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; ZN-ALPHA-2-GLYCOPROTEIN;

ABDOMINAL OBESITY; ADIPOCYTE; ADIPOCYTE HYPERTROPHY; ADIPOSE TISSUE; ADULT; AGE; ARTICLE; BODY FAT; BODY MASS; CELL DIFFERENTIATION; CELL SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENERGY EXPENDITURE; EX VIVO STUDY; FEMALE; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUT4 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHY; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; IRS1 GENE; LEAN BODY WEIGHT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MITOCHONDRION; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PGC1ALPHA GENE; PREDICTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FOLDING; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SUBCUTANEOUS FAT; TISSUE BLOOD FLOW; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; TREND STUDY; WAIST CIRCUMFERENCE; WESTERN BLOTTING; ZAG GENE; GENETICS; METABOLISM; MIDDLE AGED;

ADIPOCYTES; ADIPONECTIN; ADIPOSITY; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; GENE SILENCING; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; PREDIABETIC STATE; RNA, MESSENGER; SEMINAL PLASMA PROTEINS; SUBCUTANEOUS FAT; TRANSCRIPTION FACTORS;

EID: 84905045485     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20764     Document Type: Article

References (38)

1. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
2. Hotamisligil GS, Shargill NS, Spiegelman BM,. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
3. Ahima RS, Flier JS,. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332.
4. Rosen ED, Spiegelman BM,. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 847-853.
5. Skyba P, Ukropec J, Pobeha P, Ukropcova B, Joppa P, Kurdiova T, et al. Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease. Mediators Inflamm 2010; 2010: 173498.
6. Ukropec J, Penesova A, Skopkova M, Pura M, Vlcek M, Radikova Z, et al. Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. J Clin Endocrinol Metab 2008; 93: 2255-2262.
7. Russell ST, Tisdale MJ,. Studies on the anti-obesity activity of zinc-alpha2-glycoprotein in the rat. Int J Obes (Lond) 2011; 35: 658-665.
8. Mracek T, Stephens NA, Gao D, Bao Y, Ross JA, Ryden M, et al. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 2011; 104: 441-447.
9. Bing C, Mracek T, Gao D, Trayhurn P,. Zinc-alpha2-glycoprotein: an adipokine modulator of body fat mass? Int J Obes (Lond) 2010; 34: 1559-1565.
10. Burgi W, Schmid K,. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem 1961; 236: 1066-1074.
11. Tada T, Ohkubo I, Niwa M, Sasaki M, Tateyama H, Eimoto T,. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J Histochem Cytochem 1991; 39: 1221-1226.
12. Diez-Itza I, Sanchez LM, Allende MT, Vizoso F, Ruibal A, Lopez-Otin C,. Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur J Cancer 1993; 29A: 1256-1260.
13. Abdul-Rahman PS, Lim BK, Hashim OH,. Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. Electrophoresis 2007; 28: 1989-1996.
14. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ,. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res 1998; 58: 2353-2358.
15. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P,. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41-47.
16. Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J, et al the adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 2010; 72: 334-341.
17. Gao D, Trayhurn P, Bing C,. Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol 2010; 325: 135-142.
18. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ,. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 1998; 58: 2359-2365.
19. Russell ST, Tisdale MJ,. Studies on the antiobesity effect of zinc-alpha2-glycoprotein in the ob/ob mouse. Int J Obes (Lond) 2011; 35: 345-354.
20. Russell ST, Tisdale MJ,. Role of beta-adrenergic receptors in the oral activity of zinc-alpha2-glycoprotein (ZAG). Endocrinology 2012; 153: 4696-4704.
21. Russell ST, Tisdale MJ,. Role of beta-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-alpha2-glycoprotien (ZAG). Biochim Biophys Acta 2012; 1821: 590-599.
22. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V, et al. Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice. FEBS Lett 2007; 581: 394-400.
23. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, et al. Are skeletal muscle & adipose tissue Fndc5 gene expression and irisin release affected by obesity, diabetes and exercise? In vivo & in vitro studies. J Physiol 2014; 592: 1091-1107.
24. Malisova L, Kovacova Z, Koc M, Kracmerova J, Stich V, Rossmeislova L,. Ursodeoxycholic Acid but not tauroursodeoxycholic Acid inhibits proliferation and differentiation of human subcutaneous adipocytes. PLoS One 2013; 8: e82086.
25. Ryden M, Agustsson T, Andersson J, Bolinder J, Toft E, Arner P,. Adipose zinc-alpha2-glycoprotein is a catabolic marker in cancer and noncancerous states. J Intern Med 2012; 271: 414-420.
26. Tedeschi S, Pilotti E, Parenti E, Vicini V, Coghi P, Montanari A, et al. Serum adipokine zinc alpha2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers. Metabolism 2012; 61: 37-42.
27. Selva DM, Lecube A, Hernandez C, Baena JA, Fort JM, Simo R,. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 2009; 94: 4499-4507.
28. Garrido-Sanchez L, Garcia-Fuentes E, Fernandez-Garcia D, Escote X, Alcaide J, Perez-Martinez P, et al. Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients. PLoS One 2012; 7: e33264.
29. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A 2004; 101: 2500-2505.
30. Stejskal D, Karpisek M, Reutova H, Stejskal P, Kotolova H, Kollar P,. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 2008; 41: 313-316.
31. Yang M, Liu R, Li S, Luo Y, Zhang Y, Zhang L, et al. Zinc-alpha2- glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes. Diabet Care 2013; 36: 1074-1082.
32. Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS,. Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring) 2010; 18: 890-896.
33. Gong FY, Zhang SJ, Deng JY, Zhu HJ, Pan H, Li NS, et al. Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond) 2009; 33: 1023-1030.
34. Ceperuelo-Mallafre V, Naf S, Escote X, Caubet E, Gomez JM, Miranda M, et al. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab 2009; 94: 5062-5069.
35. Bing C, Russell ST, Beckett EE, Collins P, Taylor S, Barraclough R, et al. Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer 2002; 86: 612-618.
36. Sanders PM, Tisdale MJ,. Effect of zinc-alpha2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett 2004; 212: 71-81.
37. Russell ST, Tisdale MJ,. Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein. Endocrinology 2010; 151: 4696-4704.
38. Eckardt K, Schober A, Platzbecker B, Mracek T, Bing C, Trayhurn P, et al the adipokine zinc-alpha2-glycoprotein activates AMP kinase in human primary skeletal muscle cells. Arch Physiol Biochem 2011; 117: 88-93.